400-920-2911 sales@csnpharm.cn
您的位置 : 首页 / GPCR/G Protein / Adenosine Receptor / PQ-69
CAS No.: 910045-32-8
PQ 69 is a potent and selective A1 receptor inverse agonist taht exhibits high binding affinity at A1 receptor with Kis of 0.07 and 0.96 nM for rat and human receptors respectively.
生物活性
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
---|---|---|---|---|---|
NCT03577288 | Healthy Volunteers | Not Applicable | Not yet recruiting | July 1, 2021 | France ... more >> EA3082 Laboratoire d'Etude des Mécanismes Cognitifs Institut de Psychologie Université Lyon 2 Not yet recruiting Bron, France Contact: Hanna CHAINAY 04 78 77 43 52 ext +33 hanna.chainay@univ-lyon2.fr Principal Investigator: Hanna CHAINAY Collapse << |
NCT01154101 | Psoriasis | Phase 2 | Completed | - | United States, Missouri ... more >> GSK Investigational Site Saint Louis, Missouri, United States, 63117 United States, New York GSK Investigational Site New York, New York, United States, 10016 GSK Investigational Site New York, New York, United States, 10065 United States, Oregon GSK Investigational Site Portland, Oregon, United States, 97223 United States, Pennsylvania GSK Investigational Site Philadelphia, Pennsylvania, United States, 19103 United States, Rhode Island GSK Investigational Site Johnston, Rhode Island, United States, 02919 United States, Texas GSK Investigational Site Dallas, Texas, United States, 75246 United States, Washington GSK Investigational Site Seattle, Washington, United States, 98101 Collapse << |
NCT01154101 | - | - | Completed | - | - |
实验方案
技术信息
CAS号 | 910045-32-8 | 储存条件 |
|
|
分子式 | C20H19FN4O | 运输 | 蓝冰 | |
分子量 | 350.39 | 别名 |
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
---|
NCT03577288 | Healthy Volunteers | Not Applicable | Not yet recruiting | July 1, 2021 | France ... more >> EA3082 Laboratoire d'Etude des Mécanismes Cognitifs Institut de Psychologie Université Lyon 2 Not yet recruiting Bron, France Contact: Hanna CHAINAY 04 78 77 43 52 ext +33 hanna.chainay@univ-lyon2.fr Principal Investigator: Hanna CHAINAY Collapse << |
NCT01154101 | Psoriasis | Phase 2 | Completed | - | United States, Missouri ... more >> GSK Investigational Site Saint Louis, Missouri, United States, 63117 United States, New York GSK Investigational Site New York, New York, United States, 10016 GSK Investigational Site New York, New York, United States, 10065 United States, Oregon GSK Investigational Site Portland, Oregon, United States, 97223 United States, Pennsylvania GSK Investigational Site Philadelphia, Pennsylvania, United States, 19103 United States, Rhode Island GSK Investigational Site Johnston, Rhode Island, United States, 02919 United States, Texas GSK Investigational Site Dallas, Texas, United States, 75246 United States, Washington GSK Investigational Site Seattle, Washington, United States, 98101 Collapse << |
NCT01154101 | - | - | Completed | - | - |
联系我们
官方电话:400-920-2911
二维码
微信公众号 CSN官网